KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Align Technology (ALGN) Research & Development (2016 - 2025)

Align Technology (ALGN) has disclosed Research & Development for 17 consecutive years, with $83.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development fell 12.48% to $83.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $369.9 million, a 1.57% increase, with the full-year FY2025 number at $369.9 million, up 1.57% from a year prior.
  • Research & Development was $83.0 million for Q4 2025 at Align Technology, down from $93.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $97.2 million in Q1 2025 to a low of $54.5 million in Q1 2021.
  • A 5-year average of $81.8 million and a median of $84.4 million in 2022 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: soared 48.25% in 2021, then dropped 12.48% in 2025.
  • Align Technology's Research & Development stood at $72.5 million in 2021, then grew by 15.24% to $83.5 million in 2022, then decreased by 1.63% to $82.2 million in 2023, then increased by 15.48% to $94.9 million in 2024, then fell by 12.48% to $83.0 million in 2025.
  • Per Business Quant, the three most recent readings for ALGN's Research & Development are $83.0 million (Q4 2025), $93.3 million (Q3 2025), and $96.4 million (Q2 2025).